A new drug developed by scientists in Oxford and Cambridge has been sanctioned for use by NICE. Alemtuzemab (or Lemtrada) is said to be a “real step forward” for those in the early stages of MS.
01235 832023
01235 832023
A new drug developed by scientists in Oxford and Cambridge has been sanctioned for use by NICE. Alemtuzemab (or Lemtrada) is said to be a “real step forward” for those in the early stages of MS.